• Home
• Approach To Consun
  Company profile Management team Business Structure
• Product Center
  Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
• R&D Innovation
  R&D Platform R&D Team R&D Technology R&D Achievements
• Investor Relations
  Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact

R&D Platform

Consun has spared no effort in investment in the R&D sector, always focusing on medical and pharmaceutical technological innovation and the in-depth integration of industry, academia, and research.
Up to now, Consun has established a "Kidney Disease Drug Research Center" invested by the enterprise, with an R&D team of over 100 people. Meanwhile, it owns 1 "Postdoctoral Research Station", 1 provincial-level "Engineering Technology Research Center", 1 provincial-level "Technology Innovation Center", 1 provincial-level "Enterprise R&D Center", and 2 provincial-level "Enterprise Technology Centers".

• 

  Chinese Medicines Research Center for Renal Diseases

• 

  Postdoctoral Scientific Research Workstation

• 

  The Nephritic Drug Industrial Technology Research Center

• 

  Guangdong Enterprise Technology Center

• 

  Consun

• 

  Health Station

• 

  Micro mall

工商紅盾標(biāo)志